How to use the speech recognition tool?
Validation of standardized test protocols to assess the impact of visual pathologies in daily life activities.
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: No
Inclusion: Gr1 affected patients: Diagnosed non-syndromic pigmentary retinopathy (RP) Gr 2 healthy patients: Visual acuity of both corrected eyes (glasses, lenses) greater than or equal to 8/10 (or ≤ 0.1 logMAR)
Exclusion: MMSE score without visual item ≤ 20/25 for RP patients MMSE score with visual item ≤ 25/30 for healthy volunteers Pregnant woman
Funder Type: private, public
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators